A number of other equities analysts also recently issued reports on the stock. HSBC downgraded shares of Johnson Matthey from a “buy” rating to a “hold” rating in a research note on Monday, June 6th. Panmure Gordon upgraded shares of Johnson Matthey from a “hold” rating to a “buy” rating in a report on Wednesday, June 8th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $2,320.00.
Johnson Matthey Price Performance
JMPLY stock opened at $42.93 on Wednesday. Johnson Matthey has a 1 year low of $42.72 and a 1 year high of $77.97. The firm has a 50-day moving average of $49.98 and a 200 day moving average of $51.04. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.33 and a quick ratio of 0.84.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
- Get a free copy of the StockNews.com research report on Johnson Matthey (JMPLY)
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Is The Golden Age Of Homebuilding Already Over?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.